Veda Group Ltd to accept takeover offer: What you need to know

Veda Group Ltd (ASX:VED) shares have emerged from a trading halt.

a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Shares of data analytics business Veda Group Ltd (ASX: VED) have returned to normal trade today, rising as much as 4.3% after it confirmed Equifax has increased its takeover offer price.

So What: Equifax originally offered to pay $2.70 per share for Veda Group late last month. Although that represented a premium of 35% to Veda Group's then $1.99 price tag, Veda Group was concerned that the offer price didn't fully appreciate the company's significant growth potential.

Indeed, Veda Group enjoys a dominant position in the local credit analysis market, with significant barriers deterring the entry of other competitors. Better yet, the company is also set to benefit from the introduction of the comprehensive credit reporting regime, which has enabled strong growth in international markets in years gone by.

Essentially, this regime enhances the data that Veda Group can provide to its clients, providing them with more information regarding which customers to extend credit to.

Now What: In order to better account for this growth potential, Equifax has increased its offer price to $2.825 a share. That represents a $75 million improvement on the company's market value, and an 18.1x multiple of Veda's earnings (before interest, tax, depreciation and amortisation, or EBITDA) for the 2015 financial year.

Veda Group has agreed to recommend investors accept the Revised Proposal, assuming it proceeds to a Binding Offer after Equifax conducts its due diligence on the business.

Considering the shares are already trading within 2.2% of Equifax's offer price, it seems investors would be better off looking elsewhere for market-beating investment prospects.

Motley Fool contributor Ryan Newman has no position in any stocks mentioned. Unless otherwise noted, the author does not have a position in any stocks mentioned by the author in the comments below. You can follow Ryan on Twitter @ASXvalueinvest. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on ⏸️ Investing

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »

⏸️ Investing

Why Fox (NASDAQ:FOX) might hurt News Corp (ASX:NWS) shareholders

News Corporation (ASX: NWS) might be facing some existential threats from its American cousins over the riots on 6 January

Read more »